Ingo Vernaleken - Concepedia

Author

Ingo Vernaleken

RWTH Aachen University

Also Known As

Ingo B Vernaleken, Ingo B. Vernaleken, Ingo Bernd Vernaleken, Ingo Vernaleken, Vernaleken, Ingo B, Zalewski, M.

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

RWTH Aachen University Johannes Gutenberg University Mainz Jülich Aachen Research Alliance Ludwig-Maximilians-Universität München Aarhus University

About

Ingo Vernaleken is an author at RWTH Aachen University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.1K
2	Social Sciences	15	16	788
3	Health Sciences	3	3	107
4	Behavioral Sciences	2	2	76
5	Public Health	1	1	44

Ingo Vernaleken

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Elevated [<sup>18</sup>F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [<sup>18</sup>F]Fluorodopa/Positron Emission Tomography Study Yoshitaka Kumakura, Paul Cumming, Ingo Vernaleken, Journal of Neuroscience NeuropsychologyFdopa MetabolitesPsychopharmacologyNeurophysiological BiomarkersSocial Sciences	2007	153
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [ <sup>18</sup> F]Fallypride PET Study Gerhard Gründer, Christine Fellows, Hildegard Janouschek, American Journal of Psychiatry	2008	142
Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo Gerhard Gründer, Ingo Vernaleken, Matthias J. Müller, Neuropsychopharmacology Schizophrenic PatientsNeuropsychologyPsychiatryPsychotic DisorderPsychotropic Medication	2002	107
The Striatal and Extrastriatal D2/D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia Gerhard Gründer, Christian Landvogt, Ingo Vernaleken, Neuropsychopharmacology PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophrenia	2005	95
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. Thomas Siessmeier, Yun Zhou, Hans Georg Buchholz, PubMed	2005	83
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge Ingo Vernaleken, Yoshitaka Kumakura, Paul Cumming, NeuroImage Acute Haloperidol ChallengeNeuropsychologyNeurophysiologyMedicineHealthy Volunteers	2006	74
Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age Ingo Vernaleken, Carsten Weibrich, Thomas Siessmeier, NeuroImage NeuroanatomyPhysiologyNeurotransmitterCaudate NucleusNeuropharmacology	2006	69
‘Prefrontal’ cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: An exploratory [<sup>18</sup>F]‐fluoro‐L‐DOPA‐PET investigation Ingo Vernaleken, Hans‐Georg Buchholz, Yoshitaka Kumakura, Human Brain Mapping	2006	63
High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia Ingo Vernaleken, Thomas Siessmeier, Hans‐Georg Buchholz, The International Journal of Neuropsychopharmacology Psychotropic MedicationTracer InjectionPsychopharmacologyNeuropsychiatryPharmacotherapy	2004	60
The Impact of Dopamine on Aggression: An [<sup>18</sup>F]-FDOPA PET Study in Healthy Males Thorben Schlüter, Oliver Winz, Karsten Henkel, Journal of Neuroscience	2013	57

Page 1